2024 Rsls earnings

Rsls earnings

Author: habs

August undefined, 2024

WebApr 13, 2024 · ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations … WebMar 29, 2024 · Detailed statistics for ReShape Lifesciences Inc. (RSLS) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date Mar 29, 2024: Ex-Dividend Date n/a: Share Statistics. RSLS has 1.79 million shares outstanding. The number of shares has increased by 32.01% in one year.

RSLS ReShape Lifesciences Inc. Financial Statements - WSJ

WebMar 31, 2024 · earnings-and-revenue-growth Following the latest results, ReShape Lifesciences' twin analysts are now forecasting revenues of US$18.9m in 2024. This would be a huge 39% improvement in sales... WebMar 7, 2024 · ReShape Lifesciences, Inc. Common Stock (RSLS) Stock Price, Quote, News & History Nasdaq MY QUOTES: RSLS Edit my quotes ReShape Lifesciences, Inc. Common … gray buffalo plaid sheets

ReShape Lifesciences: RSLS Stock Price Quote & News Robinhood

WebReShape Lifesciences Inc. analyst estimates, including RSLS earnings per share estimates and analyst recommendations. WebApr 13, 2024 · ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the … WebApr 8, 2024 · Third quarter 2024 earnings released: US$0.60 loss per share (vs US$1.48 loss in 3Q 2024) Nov 16 See more updates Shareholder Returns See full shareholder returns Return vs Industry: RSLS underperformed the US Medical Equipment industry which returned -13.6% over the past year. chocolate rain some stay dry

ReShape Lifesciences (RSLS) Stock Price & Analysis

ReShape Lifesciences, Inc. Common Stock (RSLS) …

WebApr 12, 2024 · Brenmiller Energy (BNRG) -19%.GlucoTrack (GCTK) -16%.Innovative Eyewear (LUCY) -16% files patent For chatGPT enabled smart eyewear.Nouveau Monde Graphite NMG -14% launches stock offering... WebMar 28, 2024 · RSLS 24O0 SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. ( Nasdaq: RSLS ), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will delay its year ended December 31, 2024 earnings release and conference call, previously scheduled for 8:00 … gray buffalo plaid tableclothWebApr 13, 2024 · Risk and Volatility. ReShape Lifesciences has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.88, meaning that ... chocolate rain video youtube

"WebApr 3, 2024 · In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according ... " - Rsls earnings

Rsls earnings

RSLS: EnteroMedics - Detailed Earnings Estimates

WebCEO Paul F. Hickey Employees 47 Headquarters San Clemente, California Founded 2002 RSLS Key Statistics Market cap 1.38M Price-Earnings ratio -0.02 Dividend yield — Average volume 106.06K High today $2.72 Low today $2.63 Open price $2.68 Volume 44.15K 52 Week high $61.45 52 Week low $2.49 WebReShape Lifesciences Inc. (RSLS) Analyst Forecast RSLS Price, Volume, Earnings, and Dividend Date Last Price $2.93 Previous Close $3.12 Change $-0.19 Open $2.87 Volume 97,946 Avg. Volume (100-day) 543,614 Market Cap 5,257,000 Days Range 2.8 - 2.95 52-week Range 2.49 - 77 Dividend Yield — Ex. Dividend Date — P-E — EPS — Earnings Date 06/27/23

Did you know?

WebApr 3, 2024 · RSLS: EnteroMedics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. RSLS: EnteroMedics - Detailed Earnings … WebApr 6, 2024 · RSLS Stock Chart & Stats Advanced Chart > $2.75 $0.06 (2.23%) At close: Apr 06 4:00 PM EDT ― Day’s Range $0 - $0 52-Week Range $2.49 - $63.00 Previous Close $2.75 Volume 86.63K Average Volume (3M) 637.23K Market Cap $1.40M Enterprise Value -$4.49M Total Cash (Recent Filing) $6.15M Total Debt (Recent Filing) $255.00K Price to Earnings …

WebEarnings; IPO Calendar; Dividend Calendar; SPO Calendar; Holiday Calendar; Analyst Activity Analyst Recommendations; Daily Earnings Surprise; Forecast Changes; Commodities. … WebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50) …

WebApr 6, 2024 · EnteroMedics (RSLS) (Delayed Data from NSDQ) $3.08 USD -0.06 (-1.91%) Updated Mar 24, 2024 04:00 PM ET After-Market: $3.03 -0.05 (-1.62%) 7:08 PM ET Add to … WebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50)-0.01

WebRSLS Stock Price - ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. ... It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. ReShape Lifesciences Inc.'s EBITDA is -0.03.

WebApr 11, 2024 · OTCMKTS:RSLS ReShape Lifesciences - RSLS Price Target & Analyst Ratings $2.75 +0.06 (+2.23%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $2.63 $2.87 50-Day Range $2.57 $17.04 52-Week Range $2.49 $65.00 Volume 86,606 shs Average Volume 805,389 shs Market Capitalization $1.43 million P/E Ratio N/A Dividend Yield N/A … gray buffet tableWeba. Analysing RSLS's past stock price performance after earnings announcements. b. Evaluating demand and supply activities around RSLS's earnings. c. Studying the company's fundamentals. d. Keeping track of peer companies and the price changes that happen after earnings releases in the same quarter as RSLS’s scheduled announcements. gray bug in bathroomWebApr 10, 2024 · INTUITIVE SURGICAL, INC. : Q1 2024 Earnings Release (Projected) 04/25/23: DANAHER CORPORATION : Q1 2024 Earnings Release: 04/26/23: THERMO FISHER SCIENTIFIC INC. : Q1 2024 Earnings Release (Projected) 04/26/23: BOSTON SCIENTIFIC CORPORATION : Q1 2024 Earnings Release (Projected) graybug pharmaceuticalsWebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/792,094, … gray buffalo plaid drapesWebRSLS +500% upside potential according to this analyst RSLS, ReShape Lifesciences, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. chocolate raisin clustersWebApr 11, 2024 · ReShape Lifesciences (RSLS) Earnings Date & Reports 375 Followers Portfolio Earnings Data Report Date Apr 11, 2024 Before Open Not Confirmed Period … chocolate rain wikipediaWebApr 10, 2024 · Reshape Lifesciences Inc (NASDAQ:RSLS) Q4 earnings in 5 days from now on Wed Mar, 29th before market open Conference call scheduled in 5 days at 8:00 AM Click … gray bugs in house